A recently published article in Nature Medicine authored by Eric Topol, M.D., Department of Molecular Medicine, Scripps Research Institute, suggests that the convergence of human and artificial intelligence can lead to “high-performance medicine.”  High performance medicine he says, will be data driven.  The development of software that can process massive amounts of information quickly

FDA is taking steps to embrace and enhance innovation in the field of artificial intelligence. It has already permitted the marketing of an AI-based medical device (IDx-DR) to detect certain diabetes-related eye problems, a type of computer-aided detection and diagnosis software designed to detect wrist fractures in adults (OsteoDetect), and most recently, a platform